Global study of primary immunodeficiency diseases (PI)—diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation

详细信息    查看全文

• 作者：Vicki Modell (1)
  Bonnie Gee (1)
  David B. Lewis (2)
  Jordan S. Orange (3)
  Chaim M. Roifman (4)
  John M. Routes (5)
  Ricardo U. Sorensen (6)
  Luigi D. Notarangelo (7)
  Fred Modell (1)
  
• 关键词：Primary immunodeficiencies (PI) ; Jeffrey Modell Foundation (JMF) ; Jeffrey Modell Centers Network (JMCN) ; Immunoglobulin replacement therapy ; Awareness ; Economic impact ; Diagnosis ; Treatment
• 刊名：Immunologic Research
• 出版年：2011
• 出版时间：October 2011
• 年：2011
• 卷：51
• 期：1
• 页码：61-70
• 全文大小：1768KB
• 参考文献：1. Modell V. The impact of physician education and public awareness on early diagnosis of primary immunodeficiencises. Immunol Res. 2007;38:43-. CrossRef
  2. Modell F. Immunology today and new discoveries: building upon legacies of Dr. Robert A. Good. Immunol Res. 2007;38:48-0. CrossRef
  3. Cunningham-Rundles C, Ponda PP. Molecular defects in T- and B-cell primary immunodeficiency diseases. Nat Rev Immunol. 2005;5:880-2. CrossRef
  4. Cooper MA, Pommering TL, Korányi K. Primary immunodeficiencies. Am Fam Physician. 2003;68:2001-.
  5. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol. 2005;58:546-. CrossRef
  6. Chapel HM. Fortnightly review: consensus on diagnosis and management of primary antibody deficiencies. BMJ. 1994;308:581-.
  7. Modell F, Puente D, Modell V. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of Primary Immunodeficiencies. Immunol Res. Humana Press, an imprint of Springer Publishing. 2009;44(1-):132-9.
  8. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammarstrom L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161-8. Erratum in: J Allergy Clin Immunol. 2010;125:771-.
  9. Agency for Healthcare Research and Quality. 2009. http://www.hcup.ahrq.gov, January 2009.
  10. Aetna Member Navigator. 2009. http://www.member.aetna.com/member, January 2009.
  11. Bundorf KM, Royalty A, Baker LC. Health care cost growth among the privately insured. Health Aff. 2009;28(5):1294-04. CrossRef
  12. Wier LM, Marder WD. Trends in spending for physician services among the privately insured, 2004 and 2008. Thomson Reuters, April 2010.
  13. Centers for Medicare and Medicaid Services. Berenson-eggers type of service (BETOS). 2010. Retrieved 28 April 2010, from http://www.cms.gov/HCPCSReleaseCodeSets/20_BETOS.asp.
  14. Centers for Medicare and Medicaid Services. Medicare current beneficiary survey (MCBS). 2003. Retrieved 16 April 2008, from http://www.cms.gov/mcbs/downloads/HHC2003section1.pdf.
  15. Congressional Budget Office. Factors underlying the growth in medicare’s spending for physicians-services. 2007. Retrieved 28 April 2010, from http://www.cbo.gov/ftpdocs/81xx/doc8193/06-06-MedicareSpending.pdf.
  16. Fronstin P. Sources of health insurance and characteristics of the uninsured: analysis of the March 2007 current population survey. Vol 310. EBRI (Employee Benefit Research Institute) Issue Brief No. 310, October 2007, Washington, DC; 2007. p. 1-6.
  17. Raetzman S. Spending trends under employer-sponsored coverage, 1998 to 2006. Thomson Reuters; 2008.
  18. ESID—European Society for Immunodeficiencies. ESID Registry. 2003. Retrieved April 28, 2010, from http://www.esid.org/esid_registry.php.
  19. Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, Hyde C, Chapel H. UK primary immunodeficiency network. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149:410-3. CrossRef
  20. Cunningham-Rundles C. Key aspects for successful immunoglobulin therapy of primary immunodeficiencies. Clin Exp Immunol. 2011;164(Suppl 2):16-. CrossRef
  21. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22?years. J Allergy Clin Immunol. 2010;125:1354.e4-360.e4. CrossRef
  22. Gardulf A, Hammarstrom L, Smith CI. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by raPI infusion. Lancet. 1991;338:162-. CrossRef
  23. Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O’Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT. Workshop participants. Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. J Allergy Clin Immunol. 2009;124:1152.e12-160.e12. CrossRef
  24. Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, Amrolia PJ, Gaspar HB, Davies EG, Friedrich W, Hoenig M, Notarangelo LD, Mazzolari E, Porta F, Bredius RG, Lankester AC, Wulffraat NM, Seger R, Güngür T, Fasth A, Sedlacek P, Neven B, Blanche S, Fischer A, Cavazzana-Calvo M, Landais P. Inborn errors working party of the European Group for blood and marrow transplantation; European Society for Immunodeficiency. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602.e1-11-10.e1-11. CrossRef
  25. Markert ML, Devlin BH, McCarthy EA. Thymus transplantation. Clin Immunol. 2010;135:236-6. CrossRef
  26. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Gene therapy for primary adaptive immune deficiencies. J Allergy Clin Immunol. 2011;127(6):1356-. CrossRef
  27. INFO4PI—Primary Immunodeficiency Resource Center. Retrieved on April 28, 2011 http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=warningsigns&CFID=29220&CFTOKEN=75204275.
  
• 作者单位：Vicki Modell (1)
  Bonnie Gee (1)
  David B. Lewis (2)
  Jordan S. Orange (3)
  Chaim M. Roifman (4)
  John M. Routes (5)
  Ricardo U. Sorensen (6)
  Luigi D. Notarangelo (7)
  Fred Modell (1)
  
  1. Jeffrey Modell Foundation, 780 Third Avenue, 47th Floor, New York, NY, 10017, USA
  2. Department of Pediatrics, Interdepartmental Program in Immunology, and Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA, USA
  3. Division of Allergy and Immunology, Children’s Hospital of Philadelphia Research Institute, Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  4. Canadian Centre for Primary Immunodeficiency, Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada
  5. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
  6. Department of Pediatrics, Louisiana State University Health Sciences Center, Division of Allergy/Immunology, Children’s Hospital of New Orleans, New Orleans, LA, USA
  7. Division of Immunology and The Manton Center for Orphan Disease Research, Children’s Hospital Boston, Boston, MA, USA
  

文摘

A large population of patients with recurring infections are undiagnosed or under diagnosed and Primary Immunodeficiency (PI) is more common than had been previously estimated. The results strongly indicate the measurable impact of Physician Education and Public Awareness in identifying patients with an underlying PI. The Jeffrey Modell Centers Network (JMCN) provides the infrastructure for referral, diagnosis and appropriate treatment. All disease classifications and identified defects increased significantly over the study period. Quality of Life for referred and diagnosed patients dramatically improved compared to undiagnosed patients. There is a substantial cost savings for diagnosed patients compared to undiagnosed, even if regular IgG is required. The SPIRIT? Software successfully identified patients with PI in a large database and at three pilot sites. The Software was successfully tested for specificity and sensitivity.